Skip to content
← Back to this collection

PUBLICATIONS · 28209658

Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Haematologica
Publication date
2017 Jun
First author
Rohde M

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Rohde M
      type
      Author
    2. name
      Bonn BR
      type
      Author
    3. name
      Zimmermann M
      type
      Author
    4. name
      Lange J
      type
      Author
    5. name
      Möricke A
      type
      Author
    6. name
      Klapper W
      type
      Author
    7. name
      Oschlies I
      type
      Author
    8. name
      Szczepanowski M
      type
      Author
    9. name
      Nagel I
      type
      Author
    10. name
      Schrappe M
      type
      Author
    11. name
      MMML-MYC-SYS Project
      type
      CollectiveName
    12. name
      ICGC MMML-Seq Project
      type
      CollectiveName
    Complete bibliographic record and source provenance
    authors
    1. name
      Rohde M
      type
      Author
    2. name
      Bonn BR
      type
      Author
    3. name
      Zimmermann M
      type
      Author
    4. name
      Lange J
      type
      Author
    5. name
      Möricke A
      type
      Author
    6. name
      Klapper W
      type
      Author
    7. name
      Oschlies I
      type
      Author
    8. name
      Szczepanowski M
      type
      Author
    9. name
      Nagel I
      type
      Author
    10. name
      Schrappe M
      type
      Author
    11. name
      MMML-MYC-SYS Project
      type
      CollectiveName
    12. name
      ICGC MMML-Seq Project
      type
      CollectiveName
    bibliography ids
    1. nci-bib-d0e1338db88ae01437f210fd
    book metadata
    content sha256
    a7f9fbf350db89049d58ad9fedafc75a46bfcb6f4250e5b64127e3ed79e688b3
    document type
    citation
    dois
    1. 10.3324/haematol.2016.156885
    electronic publication date
    display
    2017 Feb 16
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:28209658
    immutable id
    pubmed:28209658@a7f9fbf350db89049d58ad9fedafc75a46bfcb6f4250e5b64127e3ed79e688b3
    journal
    abbreviation
    Haematologica
    issn electronic
    1592-8721
    issn print
    0390-6078
    issue
    6
    name
    Haematologica
    nlm unique id
    0417435
    pages
    1091-1098
    volume
    102
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      28209658
      provenance
      batch id
      7a1288ac8bb5f9826304
      provider
      NCBI PubMed ESummary
      record sha256
      a04350be7c2952140933db85ceaab9782a5c678059fd83ec2265211154884002
      response sha256
      0e879bec8c19d1cfda5629dca8745b04155d18cf54361825d4c070aebad2984d
      retrieved at
      2026-09-09T23:47:23.138359+00:00
      publication date
      display
      2017 Jun
      precision
      month
      year
      2017
      publication types
      1. Journal Article
      2. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/28209658/
      title
      Relevance of ID3-TCF3-CCND3 pathway mutations in pediatric aggressive B-cell lymphoma treated according to the non-Hodgkin Lymphoma Berlin-Frankfurt-Münster protocols.

      Preserved source evidence · Independent clinical review pending · Not medical advice